Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity

by Bridget N. J. Watson, Reuben B. Vercoe, George P. C. Salmond, Edze R. Westra, Raymond H. J Staals, Peter C. Fineran
Published 2019-12-01

Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands.

by Reuben B Vercoe, James T Chang, Ron L Dy, Corinda Taylor, Tamzin Gristwood, James S Clulow, Corinna Richter, Rita Przybilski, Andrew R Pitman, Peter C Fineran
Published 2013-04-01